Ortega, Juliana Festa; Conti, Aline de; Tryndyak, Volodymyr; Furtado, kelly Silva; Heidor, Renato 
; Horst, Maria Aderuza; Fernandes, Laura Helena Gasparini; Tavares, Paulo Eduardo Latorre Martins; Pogribna, Marta; Shpyleva, Svitlana; Beland, Frederick A; Pogribny, Igor P; Moreno, Fernando Salvador
Source: Oncotarget. Unidade: FCF
Subjects: HEPATOPATIAS, CARCINOMA HEPATOCELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ORTEGA, Juliana Festa et al. Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein. Oncotarget, v. 7, n. 17, p. 24339-24347, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.8248. Acesso em: 21 dez. 2024.APA
Ortega, J. F., Conti, A. de, Tryndyak, V., Furtado, kelly S., Heidor, R., Horst, M. A., et al. (2016). Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein. Oncotarget, 7( 17), 24339-24347. doi:10.18632/oncotarget.8248NLM
Ortega JF, Conti A de, Tryndyak V, Furtado kelly S, Heidor R, Horst MA, Fernandes LHG, Tavares PELM, Pogribna M, Shpyleva S, Beland FA, Pogribny IP, Moreno FS. Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein [Internet]. Oncotarget. 2016 ; 7( 17): 24339-24347.[citado 2024 dez. 21 ] Available from: https://doi.org/10.18632/oncotarget.8248Vancouver
Ortega JF, Conti A de, Tryndyak V, Furtado kelly S, Heidor R, Horst MA, Fernandes LHG, Tavares PELM, Pogribna M, Shpyleva S, Beland FA, Pogribny IP, Moreno FS. Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein [Internet]. Oncotarget. 2016 ; 7( 17): 24339-24347.[citado 2024 dez. 21 ] Available from: https://doi.org/10.18632/oncotarget.8248
